Fig. 3From: Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdownHOPE daily check-ins for buprenorphine/naloxone use and substance use. Mean proportion of each response type to daily check-ins sent by active users are listed for each month following their enrollmentBack to article page